Article Details
Retrieved on: 2024-12-30 22:25:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Precigen, Inc. (NASDAQ:PGEN), a biotechnology company specializing in gene and cell therapies with a market capitalization of $276 million, ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here